List view / Grid view

Celgene

Filter the results

 

news

NICE recommends Apremilast for treating psoriatic arthritis

11 October 2016 | By Niamh Louise Marriott, Digital Content Producer

The National Institute for Health and Care Excellence (NICE) has released draft guidance recommending Apremilast for the treatment of psoriatic arthritis in adults. This appraisal was a rapid review of the NICE technology appraisal guidance published in December 2015. It focused on cost-effectiveness analyses using a patient access scheme agreement, which provides apremilast at…

news

EC approves Revlimid for mantle cell lymphoma

15 July 2016 | By Victoria White, Digital Content Producer

Celgene’s Revlimid (lenalidomide) has been approved by the EC for the treatment of adult patients with relapsed or refractory mantle cell lymphoma...